Partnering
At NanOptima, we are advancing a pipeline of innovative product candidates designed to bring new capabilities to the treatment of prevalent ophthalmic diseases.
Collaboration is central to our mission, and we are actively seeking partnerships to expand our pipeline across diverse indications and therapeutic modalities.
Indications:
- Geographic Atrophy
- Neovascular AMD
- Retinal Fibrosis
- Diabetic Retinopathy
- Retinopathy of Prematurity
Modalities:
- Small molecules
- Antibodies
- Proteins
- Peptides
Together, we can drive transformative progress in ophthalmic care.
If you are interested in exploring partnership opportunities or learning more about our technology, we invite you to connect with us via the contact form below.